Product logins

Find logins to all Clarivate products below.


Excellus BlueCross BlueShield will have to change part of its formulary strategy as CMS prepares to ban the practice of reference-based drug pricing, used to boost generic utilization.

The national recession is sending its shockwaves in all directions, but in urban New York, Aetna is targeting small businesses and ethnic businesses with a narrow-network plan whose cost is comparable to Healthy New York.

New York may be following New Jersey's lead in expanding the definition of "dependent children" to cover more young adults.

Health Net hopes to sell its non-California business and narrow its focus, and there are several likely suitors for its business in the Tri-State. Meanwhile, Excellus' talks with the Blues of Massachusetts have raised eyebrows as well

Related Market Access Reports

Report
Catholic Health (Long Island), New York | State IDN Profile
Health Plan Analysis reports feature a comprehensive look at the managed care market within each state, plus the District of Columbia and Puerto Rico. The product assesses payer/provider influence
Report
Montefiore Health System, New York | State IDN Profile
IDN Profiles are part of Healthbase, which is an innovative platform that helps multi-disciplinary market access teams navigate the complex healthcare ecosystem with the affiliations data and insights
Report
New Jersey | 2026 | Medicaid Profile | National MCO Analyzer
State Medicaid Profiles offer a dashboard of key MCO players and enrollment, recent policy actions, and pharmacy trends for all 50 states, the District of Columbia, and Puerto Rico. Sections most
Report
Connecticut | 2026 | Medicaid Profile | National MCO Analyzer
State Medicaid Profiles offer a dashboard of key MCO players and enrollment, recent policy actions, and pharmacy trends for all 50 states, the District of Columbia, and Puerto Rico. Sections most
Report
New York | 2026 | Medicaid Profile | National MCO Analyzer
State Medicaid Profiles offer a dashboard of key MCO players and enrollment, recent policy actions, and pharmacy trends for all 50 states, the District of Columbia, and Puerto Rico. Sections most